CompletedNot Applicable

Preventive Physiotherapy Intervention in Elderly People With Sarcopenia

Spain91 participantsStarted 2014-01

Plain-language summary

This study evaluates two strength training protocols (one in peripheral muscles and one in inspiratory muscles) in the improvement of skeletal muscle mass and function in institutionalized elderly with sarcopenia. Participants will be assigned randomly in a control or one of both experimental groups.

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * People aged \> 65 years * Sarcopenia diagnosis (Tyrovolas et al., 2015) * Medically stable at least 2 months before the study Exclusion Criteria: * Cardiorespiratory, muscular, neurological, or neuromuscular disease that could interfere in the proper performance of assessment and/or training protocols. * Endocrine and metabolic disorders that might have had an effect on muscle mass. * Severe disorder of hydration status that could interfere in Bioelectrical Impedance Analysis (Rubbieri et al., 2014). * A terminal disease diagnosis. * Mini-Mental State Examination Index ≤ 20 score.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Muscle mass

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in Maximum Respiratory Pressures (MIP and MEP)

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in Handgrip strength

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in peripheral muscle strength

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Trial details

NCT IDNCT02120586

SponsorUniversity of Valencia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-03

View on ClinicalTrials.gov More Sarcopenia trials

Plain-language summary

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Muscle mass

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in Maximum Respiratory Pressures (MIP and MEP)

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in Handgrip strength

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).

Change in peripheral muscle strength

Timeframe: The groups will be assessed at baseline (pre-intervention) and at the end of the training program (week 12, post-intervention).